Cas:204707-42-6 Methyl 4-fluoro-2-methoxybenzoate manufacturer & supplier

We serve Chemical Name:Methyl 4-fluoro-2-methoxybenzoate CAS:204707-42-6 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

Methyl 4-fluoro-2-methoxybenzoate

Chemical Name:Methyl 4-fluoro-2-methoxybenzoate
CAS.NO:204707-42-6
Synonyms:Methyl 4-fluoro-2-methoxybenzoate;1OVR DF BO1;4-Fluoro-2-methoxybenzoic acid methyl ester;Benzoic acid, 4-fluoro-2-methoxy-, methyl ester;Methyl 4-fluoro-o-anisate
Molecular Formula:C9H9FO3
Molecular Weight:184.164
HS Code:2918990090

Physical and Chemical Properties:
Melting point:134-136ºC
Boiling point:231.6±20.0 °C at 760 mmHg
Density:1.2±0.1 g/cm3
Index of Refraction:1.487
PSA:35.53000
Exact Mass:184.053574
LogP:2.17

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like Methyl 4-fluoro-2-methoxybenzoate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Methyl 4-fluoro-o-anisate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4-Fluoro-2-methoxybenzoic acid methyl ester Use and application,4-Fluoro-2-methoxybenzoic acid methyl ester technical grade,usp/ep/jp grade.


Related News: The risk-based score generated by the tool helps sponsors gain advance understanding of the appropriate level of clinical supply management oversight needed to help get their project started on time and maintain momentum as the study progresses. Methyl 4-fluoro-2-methoxybenzoate manufacturer The risk-based score generated by the tool helps sponsors gain advance understanding of the appropriate level of clinical supply management oversight needed to help get their project started on time and maintain momentum as the study progresses. Methyl 4-fluoro-2-methoxybenzoate supplier ICIG will also supply materials needed for the manufacture of other treatments in earlier stages of development, including neo-GAA, currently in preclinical development as a potential next-generation Pompe disease therapy. Methyl 4-fluoro-2-methoxybenzoate vendor Though Innova previously applied for a regulatory green light, the test has not been authorized or approved by the FDA for use in the U.S.—however, during inspections of the company’s California facilities in March and April, FDA investigators said they found the test was already being sold and distributed. Methyl 4-fluoro-2-methoxybenzoate factory The CTSuccess service uses Catalent��s proprietary StartScoreTM evaluation tool to calculate the complexity of a potential clinical project across more than a dozen specific and objective study characteristics.